Building long-term wealth often comes down to consistency rather than complexity.

Instead of constantly switching between investments, investors could focus on holding a small group of quality exchange traded funds (ETFs) that can grow steadily over time.

With the right mix, it is possible to gain exposure to powerful trends, resilient businesses, and global opportunities all in one portfolio.

With that in mind, here are five ASX ETFs that could be worth buying and holding for the next decade.

VanEck Morningstar Wide Moat ETF (ASX: MOAT)

The first ASX ETF to consider is the VanEck Morningstar Wide Moat ETF.

This ETF focuses on companies with sustainable competitive advantages, often referred to as economic moats. These are businesses that can protect their profits from competitors over long periods.

Rather than simply tracking an index, the fund selects companies it believes are both high quality and attractively priced. This combination can be powerful over time, particularly when markets become more volatile.

Warren Buffett based his whole career on this investment philosophy, and given his success, it is hard to argue against using this strategy.

BetaShares Global Quality Leaders ETF (ASX: QLTY)

Another ASX ETF that could be worth considering is the BetaShares Global Quality Leaders ETF.

This ETF targets companies with strong balance sheets, high returns on equity, and consistent earnings growth. These traits are often associated with businesses that can perform well across different economic environments.

The fund includes a mix of global leaders across sectors, providing diversification while maintaining a focus on quality.

Over a 10-year period, this emphasis on financially strong companies could help smooth returns and support long-term performance. It was recently recommended by analysts at BetaShares.

BetaShares Australian Quality ETF (ASX: AQLT)

A third ASX ETF to consider is the BetaShares Australian Quality ETF.

This fund applies a similar quality-focused approach but within the Australian market. It selects ASX shares with strong profitability, low debt, and stable earnings.

This creates a portfolio that leans towards well-managed businesses rather than simply the largest companies on the ASX.

For investors looking to complement global exposure with high-quality local companies, the BetaShares Australian Quality ETF could be a useful addition to a long-term portfolio. It was also recently recommended by the team at BetaShares.

iShares Global Consumer Staples ETF (ASX: IXI)

Another ASX ETF that could be a strong long-term holding is the iShares Global Consumer Staples ETF.

This ETF provides exposure to global consumer staples companies, which produce everyday goods such as food, beverages, and household items.

These businesses tend to have stable demand regardless of economic conditions, which can provide resilience during periods of uncertainty.

Over time, consistent earnings and dividend growth from these companies can contribute to steady total returns.

BetaShares India Quality ETF (ASX: IIND)

A final ASX ETF to consider is the BetaShares India Quality ETF.

It provides exposure to high-quality stocks in India, which is one of the fastest-growing major economies in the world.

India’s expanding middle class, increasing digital adoption, and structural economic reforms are creating significant opportunities for businesses operating in the region.

By focusing on quality companies within this market, the BetaShares India Quality ETF offers a way to tap into long-term growth while maintaining a disciplined investment approach. It is another fund that was recommended by analysts at BetaShares.

The post 5 ASX ETFs to buy and hold for 10 years appeared first on The Motley Fool Australia.

More reading

• Why these ASX ETFs could be top picks in April
• A simple 3-ETF portfolio I’d use to build long-term wealth
• This simple ASX ETF strategy could quietly build serious wealth
• This ASX ETF is perfect for an uncertain world
• This simple ASX ETF strategy matters more than ever in today’s uncertain market

Motley Fool contributor James Mickleboro has positions in VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended iShares International Equity ETFs – iShares Global Consumer Staples ETF. The Motley Fool Australia has recommended VanEck Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Finding ASX shares that can double in value is no easy task.

But history shows that companies with strong competitive advantages, large market opportunities, and scalable business models can deliver outsized returns over time.

In many cases, these businesses are still early in their growth journey, which gives them a long runway to expand.

Here are three ASX shares that could have the potential to double over the next decade, or even sooner if things go their way.

Life360 Inc. (ASX: 360)

The first ASX share that could deliver strong long-term returns is Life360.

It is a family safety and location platform provider that has built a large and highly engaged global user base. Its app provides services such as real-time location sharing, driving reports, and emergency assistance.

What makes Life360 particularly compelling is its monetisation opportunity. While almost 100 million users are already on the platform, only a portion currently pay for premium features. This creates significant upside as the company continues converting free users into paying subscribers.

In addition, Life360 is expanding into new services such as advertising and partnerships, which could further increase revenue per user. With strong growth in users and improving monetisation, the business appears well positioned to scale meaningfully over time.

Netwealth Group Ltd (ASX: NWL)

Another ASX share that could be capable of doubling is Netwealth.

It provides a wealth management platform used by financial advisers and investors. Its platform allows users to manage investments, superannuation, and portfolios in a streamlined and efficient way.

The company has been consistently gaining market share from traditional providers, driven by its modern technology and user-friendly interface.

Importantly, the platform model is highly scalable. As funds under administration grow, revenue increases without a corresponding rise in costs, supporting margin expansion over time.

With structural tailwinds from the shift towards independent advice and digital platforms, Netwealth could continue growing strongly over the next decade.

Pro Medicus Ltd (ASX: PME)

A third ASX share that could deliver outsized returns is Pro Medicus.

It provides imaging software to hospitals and healthcare providers, with its Visage platform offering best-in-class, high-performance diagnostic imaging capabilities.

The company has built a strong position in the United States, where it continues to win large contracts with leading healthcare institutions. These deals are often long-term and high value, providing excellent revenue visibility.

Furthermore, the company’s business model is highly scalable. Once its software is deployed, additional usage comes at minimal incremental cost, which supports very high margins.

With a large addressable market and a proven ability to win new contracts, Pro Medicus appears well placed to continue growing. If it maintains its momentum, its shares could deliver significant returns for investors over the long term, especially after a sharp pullback in 2026.

The post 3 ASX shares that could double over the next decade (or much sooner) appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares down 25% (or more) to buy right now
• Why two experts are urging investors to buy Pro Medicus shares
• 3 ASX 200 healthcare shares to buy amid sector rout
• 3 of the best ASX 200 shares to buy this month with $6,000
• The best time to buy shares? It might be right now

Motley Fool contributor James Mickleboro has positions in Life360 and Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Life360 and Netwealth Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360 and Netwealth Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Starting out in the share market can feel intimidating. 

We have all been there. There are thousands of listed companies, constant news flow, and no shortage of opinions about what to buy.

When I think about beginner investors, I try to keep things simple. Focus on businesses that are proven, easy to understand, and have a track record of delivering over time.

Here are three ASX shares that I think fit that description.

Wesfarmers Ltd (ASX: WES)

Wesfarmers is one of the clearest examples of a high-quality Australian business.

It owns well-known consumer brands like Bunnings, Officeworks, and Kmart, which generate consistent earnings and strong cash flow. These are businesses that people interact with regularly, which makes them easier to understand as an investor.

But what I like most is management’s track record. Wesfarmers has shown over many years that it can allocate capital effectively, whether that is investing in existing divisions, expanding into new areas, or exiting businesses that no longer fit.

For a beginner, I think that kind of consistency and discipline is valuable from an ASX share.

ResMed Inc. (ASX: RMD)

ResMed offers something different. This is a global healthcare company focused on sleep and respiratory conditions, particularly sleep apnoea.

The opportunity here is large and long term. Millions of people around the world remain undiagnosed or untreated, and trends like ageing populations and increasing awareness of sleep health continue to support demand.

What stands out to me is how the business combines growth with quality. It is not just expanding. It is doing so with strong margins, solid cash flow, and a growing digital ecosystem that connects patients and providers.

For beginners, I think ResMed introduces exposure to global growth in a relatively understandable way.

Hub24 Ltd (ASX: HUB)

Hub24 brings in a different type of growth again. It operates a platform used by financial advisers to manage client investments. This is part of a broader shift toward digital wealth management.

The key driver here is scale. As more advisers use the platform and more client funds are added, the business can grow revenue while spreading its costs across a larger base.

That creates the potential for strong earnings growth over time.

It is a bit more complex than a retailer or healthcare company, but the core idea is straightforward. It is a platform that becomes more valuable as more money flows through it.

Foolish takeaway

For beginner investors, I think the goal should be to start with quality and keep things manageable.

I think Wesfarmers offers stability and a proven business model, ResMed provides exposure to long-term healthcare growth, and Hub24 adds a platform-driven growth story tied to structural changes in financial services.

Overall, I think they could be suitable starting points for a long-term portfolio.

The post 3 quality ASX shares to buy for a beginner investor appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares to buy before the next market rally
• 3 ASX defensive shares to buy in uncertain markets
• 3 reasons to buy Wesfarmers shares today
• The best time to buy shares? It might be right now
• How are these 5 ASX share giants really tracking in 2026?

Motley Fool contributor Grace Alvino has positions in Hub24 and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24, ResMed, and Wesfarmers. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Hub24 and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It was another busy week for Australia’s top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

DroneShield Ltd (ASX: DRO)

According to a note out of Bell Potter, its analysts have retained their buy rating and $4.80 price target on this counter-drone technology company’s shares. Bell Potter has been looking at the counter-drone industry and highlights that the Middle East conflict is accelerating demand for the technology. The broker notes that lessons learned in Ukraine are being repeated, including the realisation that using up to US$4 million missiles to take down US$35,000 drones is unsustainable. In light of this, Bell Potter expects there to be broad adoption of C-UAS technologies alongside advanced hypersonic defence capabilities to improve on this equation. It feels that this bodes well for DroneShield given its strong position in the market and high-quality product portfolio. The DroneShield share price ended the week at $3.93.

Navigator Global Investments Ltd (ASX: NGI)

A note out of Morgans reveals that its analysts have retained their buy rating on this investment company’s shares with a reduced price target of $2.98. Morgans I had spoken positively about the company’s decision to acquire Georgian. It is a Toronto-based AI-focused growth equity firm. The broker thinks the deal is a strategic fit and will be earnings accretive. In addition, Morgans highlights that a recent selloff of Navigator Global shares appears to be linked to private credit concerns around its key strategic partner Blue Owl. However, Morgans thinks that the company’s fundamentals are largely unchanged, creating a buying opportunity for investors. The Navigator share price was fetching $2.05 at Thursday’s close.

Nufarm Ltd (ASX: NUF)

Another note out of Bell Potter reveals that its analysts have retained their buy rating and $3.60 price target on this agricultural chemicals company’s shares. Bell Potter notes that we are entering the most material selling windows for Nufarm. The good news for Nufarm is that the majority of markets look supportive of reasonable demand levels of crop protection products. In addition, Bell Potter points out that upward movements in active ingredients and omega-3 indicators all look supportive of a reasonable pricing environment. It feels that this leaves Nufarm in a position to deleverage its balance sheet, which could be a positive share price catalyst. The Nufarm share price ended the week at $2.03.

The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.

More reading

• Brokers name 3 ASX shares to buy right now
• Why these ASX shares are rated as buys in April
• 3 ASX 200 shares down at least 30% to buy now
• $5,000 invested in Droneshield shares 4 months ago is already worth…
• Is this ASX defence stock the next DroneShield?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield and is short shares of DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Over the past few years, or even perhaps decades, passive investing has become one of the most widely-implemented strategies when it comes to building wealth on the stock market. ASX investors simply love index funds, with the ease of access, cheap management fees, and hands-off approach resonating with many Australians.

In years gone by, there were only a handful of index funds available to Australian investors, making the choice, if one had decided to go down the index fund road, easy. However, that is not really the case today. If you are searching for index funds on the ASX, there are now an overwhelming number of options one could go for. This situation, whilst good for the discerning investor, can make life tricky for those just wanting a set-and-forget strategy.

With that in mind, today, let’s go through three ASX index funds that I think amount to the best choices our market has to offer a passive investor in 2026.

Three top ASX index funds for passive investing in 2026 and beyond

First up, we have the BetaShares Australia 300 ETF (ASX: A300). This ASX index fund tracks the largest 300 stocks listed on the Australian share market. That includes everything from Commonwealth Bank of Australia (ASX: CBA) and Telstra Group Ltd (ASX: TLS) to Coles Group Ltd (ASX: COL) and Ampol Ltd (ASX: ALD).

Like most index funds (and the other two we’ll discuss in a moment), this fund is weighted by market capitalisation. That means the larger the company, the larger its slice of the index fund pie.

Full disclosure, I own an S&P/ASX 300 Index (ASX: XKO) fund, but it’s not A300. This fund only launched in August of last year, and I have held the Vanguard Australian Shares Index ETF (ASX: VAS) for many years. But A300 would be my choice for new investors, simply because it charges a lower management fee of 0.04% per annum.

Our next fund worth considering is the iShares S&P 500 ETF (ASX: IVV). This fund is similar in nature to A300. However, instead of holding the ASX’s 300 largest stocks, it holds the 500 largest companies in the American markets. That includes big tech titans like Nvidia, Tesla, Amazon, and Microsoft, as well as other American companies such as ExxonMobil, Coca-Cola, Walmart, and General Motors.

I think most ASX investors will benefit from expanding their portfolios beyond Australia’s borders, and IVV holds many of the world’s best companies. It also charges a management fee of 0.04% per annum.

Last but not least

Finally, investors may wish to consider the Vanguard MSCI Index International Shares ETF (ASX: VGS). As its name implies, this ASX index fund represents access to a number of international stock markets. That includes the US, but also Britain, Canada, Japan, Spain, Israel, Singapore, and many others. In addition to IVV’s top holdings (which VGS largely shares), this fund’s portfolio includes stocks such as Nestle, Toyota, AstraZeneca, and Shell.

If you wanted a US-centric index fund that also grants exposure to a diversified supplementation of advanced economies’ markets, VGS is a fabulous option to consider. This ETF charges a management fee of 0.18% per annum.

The post What are the ASX’s top 3 index funds for passive investing? appeared first on The Motley Fool Australia.

More reading

• 3 of the best ASX ETFs for beginner investors in 2026
• 5 ASX ETFs to buy in April and hold until 2036
• A simple 3-ETF portfolio I’d use to build long-term wealth
• Why this looks like a great time to buy the iShares S&P 500 ETF (IVV)
• Own ASX VAS or other Vanguard ETFs? Dividends just announced

Motley Fool contributor Sebastian Bowen has positions in Amazon, Coca-Cola, Microsoft, and Vanguard Australian Shares Index ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon, AstraZeneca Plc, Microsoft, Nvidia, Tesla, and iShares S&P 500 ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended General Motors and Nestlé. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool Australia has recommended Amazon, Microsoft, Nvidia, Vanguard Msci Index International Shares ETF, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Virgin Australia Holdings Ltd (ASX: VGN) shares closed on Thursday trading for $2.30.

Shares in the S&P/ASX 300 Index (ASX: XKO) airline stock, and chief competitor to Qantas Airways Ltd (ASX: QAN), have struggled in 2026.

Indeed, at Thursday’s close, Virgin Australia shares are now down 34% year to date. That trails the 18% losses posted by Qantas shares this calendar year, and is well behind the 1.55% loss on the ASX 200.

The stock is also now trading below its initial public offering (IPO), with investors who bought on the first day of trading nursing even steeper losses.

Investors able to take part in Virgin Australia’s IPO picked up shares for $2.90 apiece. The ASX 300 airline stock began trading on the ASX on 24 June. Shares opened on the day at $3.12 and closed trading for $3.23 each.

A lot of the losses in 2026 were delivered in March following the onset of the Iran war. With fuel prices surging and some travel routes facing potential disruptions, Virgin Australia stock plunged 23.6% in the month just past.

So, with shares having lost almost a third of their value in 2026, is it time to buy the dip?

Should you buy Virgin Australia shares today?

Catapult Wealth’s Blake Halligan recently analysed the outlook for the ASX 300 airline stock (courtesy of The Bull).

“The Australian airline delivered a strong result in the first half of fiscal year 2026, with underlying earnings before interest and tax increasing by 11.7% to $490 million,” Halligan said. “Revenue per available seat kilometre (RASK) was up 6.4%.”

He added:

The group’s transformation program delivered more than $200 million in gross benefits. The company has now exhausted tax losses and will begin paying tax, with franking credits at $94 million.

But with the company facing potentially increasing costs, Halligan isn’t ready to pull the trigger yet, with a hold recommendation on Virgin Australia shares.

He concluded, “While demand and yields remain supportive, rising expenses suggest a balanced hold stance.”

What’s the latest from the ASX 300 airline stock?

Virgin Australia reported its half-year results on 27 February.

Highlights included a 9.3% year-on-year increase in revenue for the six months to $3.32 billion.

But Virgin Australia shares came under some pressure, closing down 0.3% on the day, with statutory net profit after tax (NPAT) of $341 million, down 27.9%, primarily due to prior period tax benefits.

Commenting on the company’s performance on the day, Virgin Australia CEO Dave Emerson said:

The group’s continued strong performance clearly demonstrates that our constant focus on transformation and innovation is not only delivering strong financial outcomes but strengthens our ability to remain a robust competitor for years to come.

The post Down 34% in 2026, are Virgin Australia shares a good buy today? appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Northern Star, Telix, and Virgin Australia shares
• Virgin Australia shares fly 13% higher: Is this the start of the rebound we’ve all been waiting for?
• What’s next for Virgin Australia, Qantas shares as fuel prices surge?
• Virgin Australia shares slide again as global turmoil rattles key partnership
• Why Regis Resources, Strike Energy, Telix, and Virgin Australia shares are falling today

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Getting started in the share market does not require picking individual winners straight away.

Many investors choose to begin with exchange traded funds (ETFs), which can provide instant diversification and exposure to some of the world’s strongest businesses and growth trends. With just a few investments, it is possible to build a solid foundation for long-term wealth.

Here are three ASX ETFs that could be great options for those starting out in 2026.

iShares S&P 500 ETF (ASX: IVV)

The first ASX ETF that could be a strong starting point is the iShares S&P 500 ETF.

This fund provides exposure to 500 of the largest companies listed in the United States, covering a broad mix of industries including technology, healthcare, financials, and consumer goods.

What makes this ETF appealing is its simplicity. By tracking a widely followed index, it gives investors access to many of the world’s most established and profitable businesses in a single investment.

Over time, these companies have demonstrated an ability to grow earnings and adapt to changing conditions, which has supported strong long-term returns.

BetaShares S&P/ASX Australian Technology ETF (ASX: ATEC)

Another ASX ETF that could be worth considering is the BetaShares S&P/ASX Australian Technology ETF.

This fund focuses on leading technology companies listed on the ASX, offering exposure to businesses driving digital transformation across industries.

Its holdings include names such as WiseTech Global Ltd (ASX: WTC), Xero Ltd (ASX: XRO), and TechnologyOne Ltd (ASX: TNE), all of which benefit from recurring revenue and scalable platforms.

For investors looking to add a growth tilt to their portfolio, the BetaShares S&P/ASX Australian Technology ETF provides targeted exposure to Australia’s technology sector in a single trade. It was recently recommended by analysts at BetaShares.

Global X FANG+ ETF (ASX: FANG)

A third ASX ETF that could be a compelling option is the Global X FANG+ ETF.

This ETF takes a more concentrated approach, investing in a small group of global technology and innovation leaders. Its portfolio includes companies such as NVIDIA Corporation (NASDAQ: NVDA), Amazon.com Inc (NASDAQ: AMZN), and Palantir Technologies Inc (NASDAQ: PLTR).

These businesses are at the forefront of major trends such as artificial intelligence, cloud computing, and automation.

While the Global X FANG+ ETF can be more volatile than broader market funds, it offers exposure to companies with significant growth potential. For investors with a long-term mindset, that could make it an interesting addition alongside more diversified holdings. Bell Potter recently recommended this fund to clients.

The post 3 of the best ASX ETFs for beginner investors in 2026 appeared first on The Motley Fool Australia.

More reading

• 5 ASX ETFs to buy in April and hold until 2036
• Bell Potter names 2 of the best ASX ETFs to buy now
• 3 cheap ASX ETFs to buy for the tech rebound
• A simple 3-ETF portfolio I’d use to build long-term wealth
• Why this looks like a great time to buy the iShares S&P 500 ETF (IVV)

Motley Fool contributor James Mickleboro has positions in Technology One, WiseTech Global, and Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon, Nvidia, Palantir Technologies, Technology One, WiseTech Global, Xero, and iShares S&P 500 ETF. The Motley Fool Australia has positions in and has recommended WiseTech Global and Xero. The Motley Fool Australia has recommended Amazon, Nvidia, Technology One, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When a blue-chip share like CSL Ltd (ASX: CSL) falls 50% from its highs, it tends to grab attention for all the wrong reasons.

But for long-term investors, this kind of sell-off can be worth a closer look.

CSL has built its reputation over decades as one of the highest-quality companies on the ASX. It operates in global healthcare markets with strong demand, high barriers to entry, and significant pricing power. Those structural advantages have not disappeared overnight.

What has changed is sentiment, and that is often where opportunity begins.

Why have CSL shares crashed?

It is fair to say that the company’s latest half-year result was messy on the surface. Statutory profit took a major hit due to restructuring costs and impairments.

But the bigger issue was the underlying performance, particularly in its core CSL Behring division. Immunoglobulin growth came in softer than expected and, importantly, the anticipated margin recovery is taking longer to materialise.

That matters because CSL’s investment case has long been built on steady earnings growth and operating leverage. When both of those appear less certain, the market tends to reassess valuation quickly.

At the same time, the company is working through policy changes, competitive pressures, and the impacts of its transformation program. These factors have added further complexity to the outlook and raised questions about the pace of recovery.

Compounding this was leadership uncertainty following the CEO transition, which came at a time when investors were already looking for reassurance.

The long-term growth story remains intact

Despite the many negatives that are seemingly hitting all at once, CSL’s core business is still built on strong foundations.

The company continues to operate in markets with significant unmet medical need, particularly in its immunoglobulin portfolio. Management continues to point to solid long-term demand drivers, including mid to high single-digit growth across key therapies.

It is also investing for the future. The group is targeting cost savings through its transformation program, expanding its product portfolio, and positioning itself for further growth in plasma therapies, vaccines, and specialty pharmaceuticals.

These are not the actions of a business in decline. They are the actions of a company trying to reset and improve.

A rare opportunity for patient investors

High-quality ASX shares like CSL rarely trade at steep discounts without a reason. But when they do, it can present a compelling long-term opportunity.

If CSL can execute on its strategy, deliver cost savings, and continue growing its core therapies, today’s weakness could look very different in five or ten years.

A 50% decline does not guarantee a bargain. But for a company with CSL’s track record and industry position, it may represent one of those rare moments where patient investors are given a second chance.

The post Are ‘50% off’ CSL shares a once-in-a-decade opportunity? appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares to buy before the next market rally
• Why sitting out this ASX share market chaos could cost you big
• The best time to buy shares? It might be right now
• If I could buy only 1 ASX 200 share right now, it would be…
• CSL shares slide again in March — but is a comeback brewing?

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Amid all of the volatility on the stock market, there are some great ASX dividend shares that are currently trading at excellent prices. If I were given a few thousand dollars today to invest for passive income, I know which ones I’d buy.

I’d want a good dividend yield, good growth potential and an attractive valuation.

The three stocks below really tick my boxes right now.

Centuria Industrial REIT (ASX: CIP)

I think this business, a real estate investment trust (REIT), could be one of the best ideas in the sector for finding rental growth.

It’s an industrial property pure play with a national portfolio of buildings in locations where demand is strong and vacancy is low.

The ASX dividend share is benefiting from increasing demand related to tailwinds like a growing population, increasing e-commerce adoption, more data centres and so on.

In the FY26 half-year result, the business reported that its like-for-like net operating income (NOI) growth was 5.1% and it’s expecting to grow its FY26 annual distribution to 16.8 cents per unit. That translates into a forward distribution yield of 5.8%, at the time of writing.

It also reported that its HY26 net tangible assets (NTA) were $3.95 per unit at 31 December 2025, so it’s trading at a 27% discount to this at the time of writing.

WCM Global Growth Ltd (ASX: WQG)

This is a listed investment company (LIC) which looks to give investors exposure to a global portfolio of businesses with expanding economic moats and a business culture that fosters the improvement of the economic moat.

Competitive advantages are an important part of a business staying ahead of peers that want to take their market share. If those advantages are getting stronger, that’s a signal the business has more power to make bigger profits.

The impressive investment returns the ASX dividend share has generated have allowed it to steadily increase its dividend over the last several years. At the moment, it’s hiking its quarterly dividend every quarter.

It’s expecting to pay a quarterly dividend of 2.45 cents per share in a year from now in March 2027. That translates into an annualised grossed-up dividend yield of 8.2%, including franking credits, at the time of writing.

The business is trading at a discount to its latest weekly NTA before tax of $1.81 at 27 March 2026.

Pinnacle Investment Management Group Ltd (ASX: PNI)

This business is invested in a portfolio of high-quality fund managers (affiliates) and helps them grow their business.

Pinnacle can provide a wide array of behind-the-scenes services to its affiliates such as compliance, legal and client distribution. This allows the fund managers to focus on what their clients are really paying for – investment professionals delivering investment returns.

When the share markets fall it hurts the funds under management (FUM), which in turn hurts the ASX dividend share’s earnings potential in the shorter-term, but I think this cyclical nature makes it a good opportunity to buy during bear markets.

Pinnacle’s expanding portfolio of affiliates have a long-term track record of largely outperforming their benchmarks and attracting new client FUM, which is a powerful combination for growing FUM and earnings.

According to the projection on Commsec, Pinnacle could pay an annual dividend per share of 62 cents in FY26, which translates into a grossed-up dividend yield of more than 5.5%, including franking credits, at the time of writing.

The post 3 top ASX dividend share buys for passive income in April appeared first on The Motley Fool Australia.

More reading

• 2 ASX shares with dividend yields above 8%
• Three ASX 200 stock picks to consider now, to drive gains as markets and the gold price recover
• How to invest during an ASX share bear market when you’re worried about prices falling more
• 2 strong Australian stocks to buy now with $8,000
• This beaten-down ASX financial stock could deliver returns of better than 80%

Motley Fool contributor Tristan Harrison has positions in Pinnacle Investment Management Group and Wcm Global Growth. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Easter is a time for chocolate, long weekends, and maybe a bit of overindulgence.

But with cocoa prices soaring and Easter eggs costing more than ever, investors might want to consider saving the money (and the calories) and putting it to work in the share market instead.

Here are three ASX shares that could be worth considering this month.

Breville Group Ltd (ASX: BRG)

The first ASX share that could be a smart buy this Easter is Breville.

Breville designs and sells premium kitchen appliances across global markets, with its products found in countless homes throughout North America, Europe, and Australia. Its focus on innovation and quality has helped it build a strong brand and loyal customer base.

One of the key drivers of its long-term growth is its expansion in the United States. As it continues to deepen relationships with major retailers and increase brand awareness, Breville has a significant opportunity to grow its market share. This is especially the case in the booming coffee market, where Breville is having significant success.

With a scalable business model and exposure to global consumer demand, Breville could continue delivering solid growth over the years ahead.

Light & Wonder Inc. (ASX: LNW)

Another ASX share that could be worth considering is Light & Wonder.

Light & Wonder operates across gaming, digital, and social casino markets, creating content and platforms that generate recurring revenue from players around the world.

A key strength of the business is its diversification. It earns revenue from land-based gaming machines as well as digital channels, which provides multiple avenues for growth.

The company is also benefiting from the ongoing shift towards digital gaming, where engagement levels and monetisation opportunities are strong.

With a growing portfolio of popular games and platforms, Light & Wonder appears well placed to build on its momentum. And with its shares down heavily from their highs, now could be an opportune time to invest.

Xero Ltd (ASX: XRO)

A third ASX share that could be a top pick this Easter is Xero.

Xero provides cloud-based accounting software to small and medium-sized businesses, with a strong presence across Australia, New Zealand, and international markets.

Its platform plays a critical role in helping businesses manage their finances, which makes it deeply embedded in customer operations. This leads to high retention rates and recurring subscription revenue.

Looking ahead, Xero still has a large opportunity to expand globally and increase its average revenue per user through additional services. Combined with the ongoing shift towards cloud-based software, this could support long-term growth.

And while there are fears about AI disruption, Xero’s recent deal with AI giant Anthropic is starting to allay these concerns. So, with its shares down 60% from their high, this could be one to consider when the market reopens.

The post Forget Easter eggs, these ASX shares could be your best buys this month appeared first on The Motley Fool Australia.

More reading

• 1 ASX dividend share and 1 ASX growth stock to buy in April
• 3 of the best ASX 200 shares to buy this month with $6,000
• The best time to buy shares? It might be right now
• Why are ASX 200 tech stocks like WiseTech and Life360 going gangbusters on Wednesday?
• How to invest during an ASX share bear market when you’re worried about prices falling more

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Light & Wonder Inc and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Light & Wonder Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.